Delayed COVID-19 Respiratory Failure in Patients with Lymphoma on Rituximab-based Chemoimmunotherapy리툭시맙 기반 화학면역요법에 대한 림프종 환자의 지연된 COVID-19 호흡 부전Case Reports Published on 2021-06-012022-09-12 Journal: Clinical lymphoma, myeloma & leukemia [Category] MERS, SARS, 진단, [키워드] Asymptomatic Chemoimmunotherapy Chemotherapy COVID-19 death Delayed failure lymphoma onset of symptom outcome Patient receiving respiratory Respiratory failure rituximab Thrombotic complications [DOI] 10.1016/j.clml.2021.02.009 PMC 바로가기 [Article Type] Case Reports
Vaccines and Disease Relapses in Children with Nephrotic Syndrome신증후군 소아의 백신 및 질병 재발Randomized Controlled Trial Published on 2021-06-012022-09-12 Journal: Clinical journal of the American Society of Nephro [Category] MERS, SARS, 백일해, 임상, 진단, 파상풍, [키워드] Abstract children COVID-19 idiopathic nephrotic syndrome nephrotic syndrome pediatric pediatric nephrology Relapse rituximab steroid dependent nephrotic syndrome Vaccines [DOI] 10.2215/CJN.01890221 PMC 바로가기 [Article Type] Randomized Controlled Trial
The prognostic roles of hepatitis B virus antibody in diffuse large B-cell lymphoma patientsArticle Published on 2021-06-012023-06-09 Journal: Leukemia & lymphoma [Category] B형 간염, [키워드] antibody Clinical outcome diffuse large B-cell lymphoma Hepatitis B virus Prognosis rituximab [DOI] 10.1080/10428194.2020.1867726
A Rare Case of SARS-CoV-2-Induced Microscopic PolyangiitisInternal Medicine Published on 2021-05-262022-10-31 Journal: Cureus [Category] COVID-19, [키워드] acute COVID-19 Acute kidney injury acute respiratory syndrome AKI alveolar Analysis ANCA associated vasculitis antibody Antigen autoantibody Blood cellular circulating cytokine Clinical improvement contribute coronavirus Corticosteroid COVID 19 COVID-19 CT chest Cytokine storm cytoplasmic diagnosed Diagnosis differential diagnosis diffuse alveolar hemorrhage dysregulated immune response elevated female global pandemic glomerulonephritis (gn) hemoptysis hemorrhage Hyperactivation immune-cell immunosuppressive infected with SARS-CoV-2 Infection large vessel medium Microscopic Microscopic Polyangiitis Multiorgan multiple organs pathogen pathology pathophysiology Patient polyangiitis positive post-mortem biopsy Pulmonary alveolar proteinosis renal renal biopsy reported rituximab SARS-CoV-2 SARS-COV-2 infection serum creatinine Shortness of breath the patient therapy thrombotic event Trigger unique Urine Vascular Vascular injury Vasculitis [DOI] 10.7759/cureus.15259 PMC 바로가기 [Article Type] Internal Medicine
Increased risk for severe COVID-19 in patients with inflammatory rheumatic diseases treated with rituximab리툭시맙으로 치료받은 염증성 류마티스 질환 환자에서 중증 코로나19 위험 증가Comment Published on 2021-05-012022-09-12 Journal: Annals of the rheumatic diseases [Category] Fulltext, SARS, 진단, [키워드] Abstract Arthritis Arthritis, Rheumatoid B-lymphocytes Increased Inflammatory Patient rheumatic disease risk rituximab severe COVID-19 treated [DOI] 10.1136/annrheumdis-2020-218075 PMC 바로가기 [Article Type] Comment
Rituximab and risk of COVID-19 infection and its severity in patients with MS and NMOSDResearch Published on 2021-05-012022-10-27 Journal: BMC Neurology [Category] COVID-19, [키워드] case sery collected conducted Corticosteroid Course COVID-19 COVID-19 pandemic determine discharged disease Disease modifying therapy enrolled evaluated expired fatality FIVE Hospitalization ICU admission incidence incidence rate indicated infected individual Infection information Injections Mild moderate MS Multiple multiple sclerosis Neuromyelitis Optica NMO Occurrence outcome pandemic Patient patients died patients treated positive Positive test questionnaire receiving reported required Result risk of COVID-19 rituximab Safe sclerosis Self-isolation severity subject Symptom therapy use of corticosteroid [DOI] 10.1186/s12883-021-02218-4 PMC 바로가기 [Article Type] Research
Rituximab and risk of COVID-19 infection and its severity in patients with MS and NMOSDMS 및 NMOSD 환자에서 리툭시맙과 COVID-19 감염 위험 및 그 심각성Research Published on 2021-05-012022-09-01 Journal: BMC Neurology [Category] 진단, [키워드] case sery collected conducted Corticosteroid Corticosteroids Course COVID-19 COVID-19 infection COVID-19 pandemic determine disability discharged disease Disease modifying therapy enrolled evaluated expired exposure to fatality FIVE Hospitalization hospitalizations ICU admission incidence incidence rate indicated infected individual Infection information Injections Mild mild to moderate moderate MS Multiple multiple sclerosis Neuromyelitis Optica NMO Occurrence outcome pandemic Patient patients died patients treated positive Positive test questionnaire receiving reported required Result risk of COVID-19 rituximab Safe sclerosis Self-isolation severity subject Symptom test results therapy two patients use of corticosteroid walking disability [DOI] 10.1186/s12883-021-02218-4 PMC 바로가기 [Article Type] Research
Prophylactic antiviral therapy for hepatitis B virus surface antigen-positive patients with diffuse large B-cell lymphoma treated with rituximab-containing chemotherapyMulticenter Study Published on 2021-05-012023-06-13 Journal: Cancer science [Category] B형 간염, [키워드] Antiviral prophylaxis B-cell lymphoma HBsAg-positive HBV reactivation rituximab [DOI] 10.1111/cas.14846 PMC 바로가기 [Article Type] Multicenter Study
A prospective cohort study of rituximab in the treatment of refractory nephrotic syndromearticle Published on 2021-04-272024-09-02 Journal: International urology and nephrology [Category] 대상포진, [키워드] albumin EGFR Refractory nephrotic syndrome rituximab urine protein [DOI] 10.1007/s11255-021-02860-4 PMC 바로가기 [Article Type] article
Rituximab Therapy for Treatment of Pemphigus in Southeast AsiansOriginal Research Published on 2021-04-222024-09-04 Journal: Drug design, development and therapy [Category] 대상포진, [키워드] Anti-CD20 monoclonal antibody Asia autoimmune bullous pemphigus rituximab [DOI] 10.2147/DDDT.S306046 PMC 바로가기 [Article Type] Original Research